Financial Comparison
ELI Lilly And Company vs Pfizer Inc
Click a ticker to view the full analysis.
In short
ELI Lilly And Company is the more profitable of the two, keeping 31.7% of revenue as net profit against 12.4% for Pfizer Inc. ELI Lilly And Company trades at the higher trailing P/E (39.9× vs 36.6× for Pfizer Inc), so investors pay more for each dollar of its earnings. Fisclear flags 0 medium- or high-severity risks for ELI Lilly And Company and 1 for Pfizer Inc.
Based on filings for periods ending 30 Jun 2026 (LLY) and 28 Jun 2026 (PFE) · Updated
FisclearScore Comparison
FisclearScore is a quantitative model. LLY shown solid · PFE shown dashed. Not financial advice.
| Metric | LLY | PFE |
|---|---|---|
| Price | $1,169.60 | $27.82 |
| Market Cap | $1.04T | $158.6B |
| P/E (TTM) | 39.9x | 36.6x |
| P/B | 30.8x | 1.9x |
| Beta | 0.45 | 0.28 |
| Div Yield | 0.59% | 6.06% |
| Revenue (TTM) | $65.2B | $62.6B |
| Net Income | $20.6B | $7.8B |
| Gross Margin | — | — |
| Risk Flags | — | 1 flag |
Related comparisons
Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.